Page last updated: 2024-08-17

triamcinolone acetonide and Eye Cancer, Retinoblastoma

triamcinolone acetonide has been researched along with Eye Cancer, Retinoblastoma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Blair, M; Kotlyar, B; Shapiro, M1
Bianciotto, C; Say, EA; Shields, CL; Shields, JA1

Other Studies

2 other study(ies) available for triamcinolone acetonide and Eye Cancer, Retinoblastoma

ArticleYear
Exudative Retinal Detachment Following Intravitreal Chemotherapeutic Treatment for Retinoblastoma.
    Ophthalmic surgery, lasers & imaging retina, 2019, 04-01, Volume: 50, Issue:4

    Topics: Antineoplastic Agents, Alkylating; Child, Preschool; Drug Therapy, Combination; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; Humans; Injections, Intraocular; Intravitreal Injections; Macula Lutea; Male; Melphalan; Retinal Detachment; Retinal Neoplasms; Retinoblastoma; Topoisomerase I Inhibitors; Topotecan; Triamcinolone Acetonide; Ultrasonography

2019
Perilymphatic subcutaneous fat atrophy and cutaneous depigmentation after periocular triamcinolone acetonide injection in a child.
    Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus, 2011, Volume: 15, Issue:1

    Topics: Adipose Tissue; Atrophy; Brachytherapy; Fascia; Female; Glucocorticoids; Humans; Hypopigmentation; Infant; Intravitreal Injections; Retinal Neoplasms; Retinoblastoma; Skin Pigmentation; Triamcinolone Acetonide

2011